Clinical Trial Update: Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma [NA]

View source ↗

Summary

This University of Miami trial is evaluating spectroscopic MRI, proton therapy, and bevacizumab (Avastin) for recurrent glioblastoma and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Miami | Conditions: Recurrent Glioblastoma | NA | Status: RECRUITING